[Early postnatal application of glucocorticoids for preventing bronchopulmonary dysplasia in preterm infants: a Meta analysis]
- PMID: 28606229
- PMCID: PMC7390287
- DOI: 10.7499/j.issn.1008-8830.2017.06.006
[Early postnatal application of glucocorticoids for preventing bronchopulmonary dysplasia in preterm infants: a Meta analysis]
Abstract
Objective: To study the clinical effect and safety of early postnatal application of glucocorticoids in the prevention of bronchopulmonary dysplasia (BPD) in preterm infants.
Methods: The databases including PubMed, Cochrane Library, Embase, CNKI, Wanfang Data, and VIP were comprehensively searched for articles on early postnatal application of glucocorticoids in the prevention of BPD in preterm infants published up to June 2016. Review Manager 5.3 was used for the Meta analysis of 16 randomized controlled trials (RCTs) that met the inclusion criteria.
Results: A total of 2 962 participants were enrolled in the 16 RCTs, with 1 486 patients in the trial group and 1 476 in the control group. The Meta analysis showed that early postnatal application of glucocorticoids reduced the incidence rate of BPD at a corrected gestational age of 36 weeks (OR=0.73, 95%CI: 0.61-0.87, P=0.0004), but there was an increase in the risk of hyperglycemia (OR=1.61, 95%CI: 1.24-2.09, P=0.0003), hypertension (OR=1.63, 95%CI: 1.11-2.38, P=0.01), and intestinal perforation (OR=1.51, 95%CI: 1.12-2.04, P=0.007).
Conclusions: At present, it is not recommended to use glucocorticoids to prevent BPD in preterm infants. Its advantages and disadvantages need further studies, with special focuses on the adverse effects of hyperglycemia, hypertension, and intestinal perforation.
目的: 探讨早期应用糖皮质激素预防早产儿支气管肺发育不良(BPD)的疗效和安全性。
方法: 全面检索PubMed、Cochrane Library、Embase、中国期刊全文数据库(CNKI)、万方医学网及维普等数据库,收集各数据库从建库至2016年6月有关早产儿早期应用糖皮质激素预防BPD的文献,对符合纳入标准的16项随机对照试验(RCT)应用Review Manager 5.3进行Meta分析。
结果: 16项RCT共纳入2 962例参与者,其中试验组1 486例,对照组1 476例。Meta分析结果显示,早产儿早期应用糖皮质激素有利于减少纠正胎龄36周时BPD的发生率(OR=0.73,95%CI:0.61~0.87,P=0.0004);但发生高血糖(OR=1.61,95%CI:1.24~2.09,P=0.0003)、高血压(OR=1.63,95%CI:1.11~2.38,P=0.01)、肠穿孔(OR=1.51,95%CI:1.12~2.04,P=0.007)的风险增加。
结论: 目前尚不能推荐早产儿应用糖皮质激素预防BPD,需要进一步研究其优缺点,尤其需注意高血糖、高血压、肠穿孔等不良影响。
Figures
Similar articles
-
Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis.BMC Pediatr. 2023 Mar 29;23(1):139. doi: 10.1186/s12887-023-03923-4. BMC Pediatr. 2023. PMID: 36991371 Free PMC article.
-
Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.JAMA Pediatr. 2021 Jun 1;175(6):e206826. doi: 10.1001/jamapediatrics.2020.6826. Epub 2021 Jun 7. JAMA Pediatr. 2021. PMID: 33720274 Free PMC article.
-
Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis.Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F506-F511. doi: 10.1136/archdischild-2017-313759. Epub 2018 Feb 23. Arch Dis Child Fetal Neonatal Ed. 2018. PMID: 29475879 Free PMC article.
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Early postnatal corticosteroids in preventing mortality and bronchopulmonary dysplasia: the pivotal importance of selecting an appropriate treated population.Eur J Pediatr. 2024 Nov 14;184(1):10. doi: 10.1007/s00431-024-05881-0. Eur J Pediatr. 2024. PMID: 39540933
References
-
- 裘 刚, 龚 小慧. 糖皮质激素防治支气管肺发育不良的循证医学证据. http://cdmd.cnki.com.cn/Article/CDMD-10246-1015422974.htm 中国小儿急救医学. 2012;19(1):98–100.
-
- 齐 骥. 糖皮质激素防治早产儿支气管肺发育不良的进展及争议. http://www.cnki.com.cn/Article/CJFDTOTAL-XZEK201103028.htm 中国循证儿科杂志. 2011;6(3):237–240.
-
- Patterson AM, Taciak V, Lovchik J, et al. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J. 1998;17(4):321–328. doi: 10.1097/00006454-199804000-00011. - DOI - PubMed
-
- Halliday HL, Ehrenkranz RA, Doyle LW. Early ( < 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. https://www.researchgate.net/profile/Henry_Halliday/publication/41103831.... Cochrane Database Syst Rev. 2010;(1):CD001146. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous